Comment
Community-associated MRSA from the Indian subcontinent

https://doi.org/10.1016/S1473-3099(13)70231-7Get rights and content

References (16)

There are more references available in the full text version of this article.

Cited by (8)

  • Hybrid assembly of multi-drug resistant, highly virulent methicillin resistant Staphylococcus aureus ST772-SCCmec V lineage: Maximising its potential for dissemination similar to USA300 clone

    2020, Genomics
    Citation Excerpt :

    Community acquired MRSA (CA-MRSA) is often less resistant than hospital acquired MRSA (HA-MRSA). There is growing evidence of the emergence of multidrug resistant (MDR) CA-MRSA lineages across the world [1–6]. CA-MRSA clones are generally region specific, but international spread has also been documented [7,8].

  • Circulation of a community healthcare-associated multiply-resistant meticillin-resistant Staphylococcus aureus lineage in South Yorkshire identified by whole genome sequencing

    2019, Journal of Hospital Infection
    Citation Excerpt :

    CA-MRSA have traditionally been regarded as more susceptible than their HA-MRSA counterparts. However, MDR CA-MRSA clones are increasingly recognized [21,22]. MRSA with larger SCCmec elements tend to be less successful compared with community lineages which frequently encode smaller SCCmec elements such as IV and V [7,23].

  • Staphylococcus aureus 'Down Under': Contemporary epidemiology of S. aureus in Australia, New Zealand, and the South West Pacific

    2014, Clinical Microbiology and Infection
    Citation Excerpt :

    Like other CA-MRSA clones, ST30-IV harbours the lukF-PV/lukS-PV genes and is predominantly associated with skin infections in otherwise healthy individuals, although recent data suggest that ST30-IV is also responsible for a sizeable proportion of MRSA infections in patients with prior healthcare exposure 55. Recent phylogenomic analysis suggests that South West Pacific ST30-IV may have emerged independently from an ancestral CC30 clone in 1967, although this study did not include isolates from New Zealand or Samoa 56. Since 2005, an ST5-IV clone has rapidly displaced ST30-IV as the predominant CA-MRSA clone in New Zealand, accounting for approximately half of all MRSA in a national period-prevalence survey in 2012 26.

  • Guidelines for antibiotic prescription in intensive care unit

    2019, Indian Journal of Critical Care Medicine
View all citing articles on Scopus
View full text